Update on microbe-induced epigenetic changes: Bacterial effectors and viral oncoproteins as epigenetic dysregulators

Future Virology

Volumn 8, Issue 11, 2013, Pages 1111-1126

  Niller, Hans Helmut ^a   Banati, Ferenc ^b   Nagy, Katalin ^c   Buzas, Krisztina ^c   Minarovits, Janos ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b RT Europe Nonprofit Ltd   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

DNA methylation; epigenetic regulation; histone modification; oncovirus; pathoepigenetics; pioneer transcription factor; Polycomb and Trithorax complexes; tumorigenesis

Indexed keywords

COHESIN; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ONCOPROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR CTCF; VIRUS PROTEIN;

AEROMONAS HYDROPHILA; ANAPLASMA PHAGOCYTOPHILUM; BACTERIAL VIRULENCE; BORDETELLA BRONCHISEPTICA; BURKHOLDERIA THAILANDENSIS; CAMPYLOBACTER RECTUS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CLOSTRIDIUM PERFRINGENS; DNA METHYLATION; DNA VIRUS; EPIGENETICS; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; GENOTYPE; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; INFLAMMATION; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPIC VARIATION; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA VIRUS; SHIGELLA FLEXNERI; STREPTOCOCCUS PNEUMONIAE; TUMOR VIRUS; UROPATHOGENIC ESCHERICHIA COLI; VIRUS CARCINOGENESIS; VIRUS GENOME; WART VIRUS;

EID: 84886672994     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.13.97     Document Type: Review

References (151)

1. Aravind L, Abhiman S, Iyer LM. Natural history of the eukaryotic chromatin protein methylation system. Prog. Mol. Biol. Transl. Sci. 101, 105-176 (201).
2. Jeltsch A. Oxygen, epigenetic signaling, and the evolution of early life. Trends Biochem. Sci. 38(4), 172-176 (2013).
3. Jin B, Li Y, Robertson KD. DNA methylation: Superior or subordinate in the epigenetic hierarchy? Genes Cancer. 2(6), 607-617 (201).
4. Jurkowski TP, Jeltsch A. On the evolutionary origin of eukaryotic DNA methyltransferases and Dnmt2. PLoS ONE 6(1), e28104 (201).
5. Coyne RS, Lhuillier-Akakpo M, Duharcourt S. RNA-guided DNA rearrangements in ciliates: Is the best genome defence a good offence? Biol. Cell 104(6), 309-325 (2012).
6. Fisk JC, Read LK. Protein arginine methylation in parasitic protozoa. Eukaryot. Cell 10(8), 1013-1022 (201).
7. Hoeijmakers WA, Stunnenberg HG, Bartfai R. Placing the Plasmodium falciparum epigenome on the map. Trends Parasitol. 28(1), 486-495 (2012).
8. Niller HH, Banati F, Ay E, Minarovits J. Microbe-induced epigenetic alterations. In: Patho-Epigenetics of Disease. Minarovits J, Niller HH (Eds). Springer, NY, USA, 419-455 (2012
9. Kishore SP, Stiller JW, Deitsch KW. Horizontal gene transfer of epigenetic machinery and evolution of parasitism in the malaria parasite Plasmodium falciparum and other apicomplexans. BMC Evol. Biol. 13, 37 (2013).
10. Casadesus J, Low DA. Programmed heterogeneity: epigenetic mechanisms in bacteria. J. Biol. Chem. 288(20), 13929-13935 (2013).
11. Manzur KL, Zhou MM. An archaeal SET domain protein exhibits distinct lysine methyltransferase activity towards DNA-associated protein MC1-alpha. FEBS Lett. 579(17), 3859-3865 (2005).
12. Niu Y, Xia Y, Wang S et al. A prototypic lysine methyltransferase 4 from archaea with degenerate sequence specificity methylates chromatin proteins Sul7d and Cren7 in different patterns. J. Biol. Chem. 288(19), 13728-13740 (2013).
13. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 20(24), 3139-3155 (2001).
14. Araujo FD, Croteau S, Slack AD et al. The DNMT1 target recognition domain resides in the N terminus. J. Biol. Chem. 276(10), 6930-6936 (2001).
15. Hervouet E, Lalier L, Debien E et al. Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS ONE 5(6), e1333 (2010).
16. Hervouet E, Nadaradjane A, Gueguen M, Vallette FM, Cartron PF. Kinetics of DNA methylation inheritance by the Dnmt1- including complexes during the cell cycle. Cell Div. 7, 5 (2012).
17. Iida T, Suetake I, Tajima S et al. PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes Cells 7(10), 997-1007 (2002).
18. Spada F, Haemmer A, Kuch D et al. DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells. J. Cell Biol. 176(5), 565-571 (2007).
19. Jeong S, Liang G, Sharma S et al. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol. Cell Biol. 29(19), 5366-5376 (2009).
20. Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet. 10(1), 805-81 (2009).
21. Gatto S, D'Esposito M, Matarazzo MR. The role of DNMT3B mutations in the pathogenesis of ICF syndrome. In: Patho- Epigenetics of Disease. Minarovits J, Niller HH (Eds). Springer, NY, USA, 15-41 (2012).
22. Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 25(23), 2436-2452 (201).
23. Smith ZD, Meissner A. The simplest explanation: passive DNA demethylation in PGCs. EMBO J. 32(3), 318-321 (2013).
24. Aoto T, Saitoh N, Sakamoto Y, Watanabe S, Nakao M. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression. J. Biol. Chem. 283(27), 18905-18915 (2008).
25. Blobel GA, Kadauke S, Wang E et al. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol. Cell. 36(6), 970-983 (2009).
26. Cloos PA, Christensen J, Agger K, Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22(9), 15-140 (2008).
27. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nat. Rev. Genet. 10(1), 32-42 (2009).
28. Kelly TK, Miranda TB, Liang G et al. H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. Mol. Cell. 39(6), 901-91 (2010).
29. Kelly TK, Jones PA. Role of nucleosomes in mitotic bookmarking. Cell Cycle. 10(3), 370-371 (201).
30. Burgess RJ, Zhang Z. Histone chaperones in nucleosome assembly and human disease. Nat. Struct. Mol. Biol. 20(1), 14-22 (2013).
31. Begum NA, Stanlie A, Nakata M, Akiyama H, Honjo T. The histone chaperone Spt6 is required for activation-induced cytidine deaminase target determination through H3K4me3 regulation. J. Biol. Chem. 287(39), 32415-32429 (2012).
32. Stevenson JS, Liu H. Nucleosome assembly factors CAF-1 and HIR modulate epigenetic switching frequencies in an H3K56 acetylation-associated manner in Candida albicans. Eukaryot. Cell 12(4), 591-603 (2013).
33. Wang AH, Zare H, Mousavi K et al. The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis. EMBO J. 32(8), 1075-1086 (2013).
34. Zaret KS, Watts J, Xu J, Wandzioch E, Smale ST, Sekiya T. Pioneer factors, genetic competence, and inductive signaling: programming liver and pancreas progenitors from the endoderm. Cold Spring Harb. Symp. Quant. Biol. 73, 19-126 (2008).
35. Nie L, Wu HJ, Hsu JM et al. Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am. J. Transl. Res. 4(2), 127-150 (2012).
36. Doerfler W. The impact of foreign DNA integration on tumor biology and evolution via epigenetic alterations. In: Patho-Epigenetics of Disease. Minarovits J, Niller HH (Eds). Springer, NY, USA, 14-378 (2012).
37. Gyory I, Minarovits J. Epigenetic regulation of lymphoid specific gene sets. Biochem. Cell Biol. 83(3), 286-295 (2005).
38. Burke LJ, Zhang R, Bartkuhn M et al. CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin. EMBO J. 24(18), 3291-3300 (2005).
39. Jones PA, Baylin SB. The epigenomics of cancer. Cell 128(4), 683-692 (2007).
40. Minarovits J. Microbe-induced epigenetic alterations in host cells: The coming era of patho-epigenetics of microbial infections. A review. Acta Microbiol. Immunol. Hung. 56(1), 1-19 (2009).
41. Minarovits J, Niller HH. Patho-Epigenetics of Disease. Minarovits J, Niller HH (Eds). Springer, NY, USA (2012).
42. Tollefsbol TO. Epigenetics in Human Disease. Tollefsbol TO (Ed.). Academic Press, MA, USA (2012).
43. Niller HH, Banati F, Ay E, Minarovits J. Epigenetic changes in virus-associated neoplasms. In: Patho-Epigenetics of Disease. Minarovits J, Niller HH (Eds). Springer, NY, USA, 179-225 (2012).
44. Mikovits JA, Young HA, Vertino P et al. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol. Cell Biol. 18(9), 5166-5177 (1998).
45. Bierne H, Hamon M, Cossart P. Epigenetics and bacterial infections. Cold Spring Harb. Perspect. Med. 2(12), a010272 (2012).
46. Niller HH, Minarovits J. Epigenetics and human infectious diseases. In: Epigenetics in Human Disease. Tollefsbol TO (Ed.). Academic Press, MA, USA, 415-442 (2012).
47. Li T, Lu Q, Wang G et al. SET-domain bacterial effectors target heterochromatin protein 1 to activate host rDNA transcription. EMBO Rep. 14(8), 733-740 (2013).
48. Ushijima T. Epigenetic field for cancerization. J. Biochem. Mol. Biol. 40(2), 142-150 (2007).
49. Hamon M, Bierne H, Cossart P. Listeria monocytogenes: A multifaceted model. Nat. Rev. Microbiol. 4(6), 423-434 (2006).
50. Hamon MA, Batsche E, Regnault B et al. Histone modifications induced by a family of bacterial toxins. Proc. Natl Acad. Sci. USA 104(33), 13467-13472 (2007).
51. Hamon MA, Cossart P. K+ efflux is required for histone H3 dephosphorylation by Listeria monocytogenes listeriolysin O and other pore-forming toxins. Infect. Immun. 79(7), 2839-2846 (201).
52. Bierne H, Tham TN, Batsche E et al. Human BAHD1 promotes heterochromatic gene silencing. Proc. Natl Acad. Sci. USA 106(33), 13826-13831 (2009).
53. Lebreton A, Lakisic G, Job V et al. A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science 331(6022), 1319-1321 (201).
54. Darveau RP. The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol. 28(8), 389-395 (2009).
55. Uehara O, Abiko Y, Saitoh M, Miyakawa H, Nakazawa F. Lipopolysaccharide extracted from Porphyromonas gingivalis induces DNA hypermethylation of runt-related transcription factor 2 in human periodontal fibroblasts. J.Microbiol.Immunol.Infect. doi:10.1016/j. jmii.2012.08.005 (2012) (Epub ahead of print).
56. de Camargo Pereira G, Guimaraes GN, Planello AC et al. Porphyromonas gingivalis LPS stimulation downregulates DNMT1, DNMT3a, and JMJD3 gene expression levels in human HaCaT keratinocytes. Clin. Oral Investig. 17(4), 1279-1285 (2013).
57. Imai K, Ochiai K, Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. J. Immunol. 182(6), 3688-3695 (2009).
58. Imai K, Ochiai K. Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression. J. Oral Sci. 53(1), 1-13 (201).
59. Garcia-Garcia JC, Barat NC, Trembley SJ, Dumler JS. Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog. 5(6), e1000488 (2009).
60. Garcia-Garcia JC, Rennoll-Bankert KE, Pelly S, Milstone AM, Dumler JS. Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect. Immun. 77(6), 2385-2391 (2009).
61. Rennoll-Bankert KE, Dumler JS. Lessons from Anaplasma phagocytophilum: Chromatin remodeling by bacterial effectors. Infect. Disord. Drug Targets 12(5), 380-387 (2012).
62. Rolando M, Sanulli S, Rusniok C et al. Legionella pneumophila effector RomA uniquely modifies host chromatin to repress gene expression and promote intracellular bacterial replication. Cell Host. Microbe. 13(4), 395-405 (2013).
63. Schmeck B, Lorenz J, N'guessan PD et al. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. J. Immunol. 181(2), 940-947 (2008).
64. Henderson JP, Crowley JR, Pinkner JS et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 5(2), e1000305 (2009).
65. O'Shea B, Khare S, Klein P et al. Amplified fragment length polymorphism reveals specific epigenetic distinctions between Mycobacterium avium subspecies paratuberculosis isolates of various isolation types. J. Clin. Microbiol. 49(6), 2222-2229 (201).
66. Tolg C, Sabha N, Cortese R et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab. Invest. 91(6), 825-836 (201).
67. Tolg C, Bagli DJ. Uropathogenic Escherichia coli infection: potential importance of epigenetics. Epigenomics. 4(2), 229-235 (2012).
68. Schulz WA. Uropathogenic bacteria leave a mark. Lab. Invest. 91(6), 816-818 (201).
69. Pathak SK, Basu S, Bhattacharyya A et al. TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J. Immunol. 177(1), 7950-7958 (2006).
70. Chiariotti L, Angrisano T, Keller S et al. Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk. Med.Microbiol.Immunol. 202(5), 327-337 (2013).
71. Cheng AS, Li MS, Kang W et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 144(1), 122-133 (2013).
72. Niwa T, Toyoda T, Tsukamoto T, Mori A, Tatematsu M, Ushijima T. Prevention of Helicobacter pylori-induced gastric cancers in gerbils by a DNA demethylating agent. Cancer Prev. Res. (Phila.) 6(4), 263-270 (2013).
73. Niwa T, Tsukamoto T, Toyoda T et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 70(4), 1430-1440 (2010).
74. Wang Y, Curry HM, Zwilling BS, Lafuse WP. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J. Immunol. 174(9), 5687-5694 (2005).
75. Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J. Immunol. 176(7), 4323-4330 (2006).
76. Pennini ME, Liu Y, Yang J, Croniger CM, Boom WH, Harding CV. CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein. J. Immunol. 179(10), 6910-6918 (2007).
77. Andraos C, Koorsen G, Knight JC, Bornman L. Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum. Immunol. 72(3), 262-268 (201).
78. Esterhuyse MM, Linhart HG, Kaufmann SH. Can the battle against tuberculosis gain from epigenetic research? Trends Microbiol. 20(5), 220-226 (2012).
79. Niller HH, Wolf H, Minarovits J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin. Cancer Biol. 19(3), 158-164 (2009).
80. Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 152(1-2), 51-67 (2013).
81. Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 6(3), 273-283 (201).
82. McCall CE, Yoza B, Liu T, El Gazzar M. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate. Immun. 2(5), 395-405 (2010).
83. El Gazzar M, Yoza BK, Chen X, Hu J, Hawkins GA, McCall CE. G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance. J. Biol. Chem. 283(47), 32198-32208 (2008).
84. Chen X, Yoza BK, El Gazzar M, Hu JY, Cousart SL, McCall CE. RelB sustains IkappaBalpha expression during endotoxin tolerance. Clin. Vaccine Immunol. 16(1), 104-10 (2009).
85. Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 286(1), 9856-9864 (201).
86. Zhang S, Barros SP, Moretti AJ et al. Epigenetic regulation of TNFA expression in periodontal disease. J. Periodontol. doi:10.1902/jop.2013.120294 (2013) (Epub ahead of print).
87. Niller HH. Myelodysplastic syndrome (MDS) as a late stage of subclinical hemophagocytic lymphohistiocytosis (HLH): A putative role for Leptospira infection. A hypothesis. Acta Microbiol. Immunol. Hung. 57(3), 181-189 (2010).
88. Munoz P, Iliou MS, Esteller M. Epigenetic alterations involved in cancer stem cell reprogramming. Mol. Oncol. 6(6), 620-636 (2012).
89. Minarovits J, Niller HH. Patho-epigenetics. Med. Epigenetics 1(1), 37-45 (2013).
90. Javier RT, Butel JS. The history of tumor virology. Cancer Res. 68(19), 7693-7706 (2008).
91. Pagano JS, Blaser M, Buendia MA et al. Infectious agents and cancer: Criteria for a causal relation. Semin. Cancer Biol. 14(6), 453-471 (2004).
92. Poreba E, Broniarczyk JK, Gozdzicka-Jozefiak A. Epigenetic mechanisms in virus-induced tumorigenesis. Clin. Epigenetics. 2(2), 233-247 (201).
93. Liebowitz D. Epstein-Barr virus pathogenesis. In: Human Tumor Viruses. McCance DJ (Ed.). ASM Press, Washington, DC, USA, 175-199 (1998).
94. Seo SY, Kim EO, Jang KL. Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation. Cancer Lett. 270(1), 66-76 (2008).
95. Tsai CL, Li HP, Lu YJ et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res. 66(24), 1668-1676 (2006).
96. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl Acad. Sci .USA 99(15), 10084-10089 (2002).
97. Leonard S, Wei W, Anderton J et al. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J. Virol. 85(18), 9568-9577 (201).
98. Hino R, Uozaki H, Murakami N et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 69(7), 2766-2774 (2009).
99. Minarovits J. Epigenotypes of latent herpesvirus genomes. Curr. Top. Microbiol. Immunol. 310, 61-80 (2006).
100. Hughes DJ, Marendy EM, Dickerson CA, Yetming KD, Sample CE, Sample JT. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J. Virol. 86(2), 1034-1045 (2012).
101. Tempera I, Klichinsky M, Lieberman PM. EBV latency types adopt alternative chromatin conformations. PLoS Pathog. 7(7), e1002180 (201).
102. Salamon D, Banati F, Koroknai A et al. Binding of CCCTC-binding factor in vivo to the region located between Rep and C-promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. J. Gen. Virol. 90(Pt 5), 183-189 (2009).
103. Takacs M, Banati F, Koroknai A et al. Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim. Biophys. Acta 1799(3-4), 228-235 (2010).
104. Holdorf MM, Cooper SB, Yamamoto KR, Miranda JJ. Occupancy of chromatin organizers in the Epstein-Barr virus genome. Virology 415(1), 1-5 (201).
105. Zetterberg H, Borestrom C, Nilsson T, Rymo L. Multiple EBNA1-binding sites within oriPl are required for EBNA1- dependent transactivation of the Epstein-Barr virus C promoter. Int. J. Oncol. 25(3), 693-696 (2004).
106. Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J. The LCR of EBV makes Burkitt's lymphoma endemic. Trends Microbiol. 12(1), 495-499 (2004).
107. Nayyar VK, Shire K, Frappier L. Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J. Cell Sci. 122(Pt 23), 4341-4350 (2009).
108. Dutton A, Woodman CB, Chukwuma MB et al. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood 109(6), 2597-2603 (2007).
109. Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res. 40(15), 7233-7246 (2012).
110. Anderton JA, Bose S, Vockerodt M et al. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's lymphoma. Oncogene 30(17), 2037-2043 (201).
111. Du ZM, Hu LF, Wang HY et al. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS ONE 6(4), e19137 (201).
112. Lin IG, Tomzynski TJ, Ou Q, Hsieh CL. Modulation of DNA binding protein affinity directly affects target site demethylation. Mol. Cell Biol. 20(7), 2343-2349 (2000).
113. Niller HH, Minarovits J. Similarities between the Epstein-Barr virus (EBV) nuclear protein EBNA1 and the pioneer transcription factor FoxA: Is EBNA1 a 'bookmarking' oncoprotein that alters the host cell epigenotype? Pathogens 1, 37-51 (2012).
114. Portal D, Rosendorff A, Kieff E. Epstein- Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc. Natl Acad. Sci. USA 103(51), 19278-19283 (2006).
115. Wang L, Grossman SR, Kieff E. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl Acad. Sci. USA 97(1), 430-435 (2000).
116. Kim KY, Huerta SB, Izumiya C et al. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. J. Virol. 87(12), 6782-6793 (2013).
117. Shamay M, Krithivas A, Zhang J, Hayward SD. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc. Natl Acad. Sci. USA 103(39), 14554-14559 (2006).
118. Stuber G, Mattsson K, Flaberg E et al. HHV- 8 encoded LANA-1 alters the higher organization of the cell nucleus. Mol. Cancer. 6, 28 (2007).
119. Mattsson K, Kiss C, Platt GM et al. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J. Gen. Virol. 83(Pt 1), 179-188 (2002).
120. Viejo-Borbolla A, Ottinger M, Bruning E et al. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J. Virol. 79(21), 13618-13629 (2005).
121. Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat. Res. 727(3), 55-61 (201).
122. Park IY, Sohn BH, Yu E et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132(4), 1476-1494 (2007).
123. van Regenmortel MHV, Fauquet CM, Bishop DHL et al. Virus taxonomy. In: The Classification and Nomenclature of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses (ICTV). van Regenmortel MHV, Fauquet CM, Bishop DHL et al. (Eds). Academic Press, MA, USA (2000).
124. Benegiamo G, Vinciguerra M, Guarnieri V, Niro GA, Andriulli A, Pazienza V. Hepatitis delta virus induces specific DNA methylation processes in Huh-7 liver cancer cells. FEBS Lett. 587(9), 1424-1428 (2013).
125. Wong DK, Walker BD. Hepatitis C virus. In: Human Tumor Viruses. McCance DJ (Ed.). ASM Press, MA, USA, 301-329 (1998
126. Arora P, Kim EO, Jung JK, Jang KL. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett. 261(2), 244-252 (2008).
127. Ripoli M, Barbano R, Balsamo T et al. Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Res. 160(1-2), 74-81 (201).
128. Stunkel W, Campbell RM. Sirtuin 1 (SIRT1): The misunderstood HDAC. J. Biomol. Screen. 16(10), 153-169 (201).
129. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2(5), 342-350 (2002).
130. Nead MA, McCance DJ. Activities of the transforming proteins of human papillomaviruses. In: Human tumor viruses. McCance DJ (Ed.). ASM Press, MA, USA, 225-251 (1998
131. Holland D, Hoppe-Seyler K, Schuller B et al. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res. 68(23), 9964-9972 (2008).
132. Hyland PL, McDade SS, McCloskey R et al. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus Type 16 E6/E7- expressing keratinocytes. J. Virol. 85(21), 10999-1006 (201).
133. Szalmas A, Konya J. Epigenetic alterations in cervical carcinogenesis. Semin. Cancer Biol. 19(3), 144-152 (2009).
134. Lechner M, Fenton T, West J et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med. 5(2), 15 (2013).
135. McLaughlin-Drubin ME, Crum CP, Munger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc. Natl Acad. Sci. USA 108(5), 2130-2135 (201).
136. Newman CL, Rosenblatt JD. Human T-cell lymphotropic viruses. In: Human Tumor Viruses. McCance D (Ed.). ASM Press, Washington, DC, USA, 331-357 (1998
137. Kehn K, Fuente CL, Strouss K et al. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 24(4), 525-540 (2005).
138. Cheng H, Ren T, Sun SC. New insight into the oncogenic mechanism of the retroviral oncoprotein Tax. Protein Cell. 3(8), 581-589 (2012).
139. Ishikawa C, Kawakami H, Uchihara JN, Senba M, Mori N. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation. Biochim. Biophys. Acta 1833(6), 1542-1552 (2013).
140. Nakachi S, Nakazato T, Ishikawa C et al. Human T-cell leukemia virus type 1 tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling. Biochim. Biophys. Acta 1813(5), 731-741 (201).
141. Jeong SJ, Lu H, Cho WK, Park HU, Pise-Masison C, Brady JN. Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax. J. Virol. 80(20), 10036-10044 (2006).
142. Nyborg JK, Egan D, Sharma N. The HTLV-1 Tax protein: revealing mechanisms of transcriptional activation through histone acetylation and nucleosome disassembly. Biochim. Biophys. Acta 1799(3-4), 266-274 (2010).
143. Cheng J, Kydd AR, Nakase K et al. Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein. Blood 10(6), 210-2120 (2007).
144. Zhao T, Matsuoka M. HBZ and its roles in HTLV-1 oncogenesis. Front. Microbiol. 3, 247 (2012).
145. Ay E, Buzas K, Banati F, Minarovits J. Recent results in the development of fetal immune system: Self, epigenetic regulation, fetal immune responses. In: Maternal Fetal Transmission Of Human Viruses And Their Influence On Tumorigenesis. Berencsi G (Ed.). Springer, NY, USA, 51-82 (2012).
146. Polakowski N, Gregory H, Mesnard JM, Lemasson I. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain. Retrovirology 7, 61 (2010).
147. Wurm T, Wright DG, Polakowski N, Mesnard JM, Lemasson I. The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP. Nucleic Acids Res. 40(13), 5910-5925 (2012).
148. Holeski LM, Jander G, Agrawal AA. Transgenerational defense induction and epigenetic inheritance in plants. Trends Ecol. Evol. 27(1), 618-626 (2012).
149. Malmquist NA, Moss TA, Mecheri S, Scherf A, Fuchter MJ. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 109(41), 16708-16713 (2012).
150. Sumanadasa SD, Goodman CD, Lucke AJ et al. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939. Antimicrob. Agents Chemother. 56(7), 3849-3856 (2012).
151. Ay E, Banati F, Mezei M et al. Epigenetics of HIV infection: promising research areas and implications for therapy. AIDS Rev. 15(3), 181-188 (2013).